I was thinking about this and I agree it has to be perfect.
I was thinking about this and I agree it has to be perfect. However we should also understand that the PR from the company is not to do the job of the media/journalists. Nader was very clear a few CC ago that they do not need advice on how to write a PR, They are under scrutiny from the SEC and their own lawyers to only say what is factually correct. They are not to embellish too much or educate the reader as to what the PR means at any level for the most part.
It is the job of a journalist to read the PR and ask questions of the company. They then translate in their own way to their readers. They are the ones to point out the significance, the impact, the scope the science explanation. It is better the media translates and presents info, they are not under SEC or nearly the legal constraints that stops a company from over embellishing the meaning of the PR. The PR is to be a matter of fact declaration.
We all went down this road a couple months ago trying to re-write the PRs the way we want them. We should focus on the media picking this up and getting the story, not expecting the PR to do the work of a blog post, twitter, newspaper article etc..
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
U.S. Latino leaders gathered for a historic delegation to Mexico, coinciding with the inauguration of Dra. Claudia Sheinbaum Pardo as Mexico's first female president back in 2024. This was no ordinary trip; it was a strategic move to tighten bonds between the two nations at a pivotal moment, hoping to reshape how Mexican-Americans influenced U.S. policy. Binational Ties:...
Continue Reading
The Future of Structural Heart Devices Market Growth The structural heart devices market is on an impressive growth trajectory, projected to reach approximately USD 25 billion within the coming years. This expansion is primarily driven by the escalating demand for innovative solutions to manage various structural heart conditions. Understanding Structural Heart Devices...
Continue Reading
Significant Changes at MediPharm Labs MediPharm Labs Corp. (TSX: LABS, OTCQX: MEDIF), a leader in pharmaceutical-quality cannabis extraction and hemp-based products, has announced the departure of its President and Co-Founder, Keith Strachan, from his management role. Effective immediately, Keith will transition to the Board of Directors, where his strategic input will...
Continue Reading
Interactive Brokers Group Reports Strong Financial Growth Interactive Brokers Group (NASDAQ: IBKR) has announced impressive financial results for the third quarter of 2024, capitalizing on a beneficent market following a U.S. interest rate cut. The company experienced significant year-over-year growth across key metrics such as client accounts, equity, and revenue....
Continue Reading
Overview of Recent Share Trading Activities Publicis Groupe has recently engaged in trading its own shares as part of a program approved during its Shareholders’ Meetings. This initiative underscores the company's commitment to managing its share capital effectively, reflecting its ongoing strategy to enhance shareholder value. Transaction Details During the designated...
Continue Reading